Send me a link:

*Text messaging rates may apply.

 Dow Down0.50% Nasdaq Up0.14%

Avanir Pharmaceuticals, Inc. (AVNR)

-NasdaqGS
5.36 Up 0.02(0.37%) 11:56AM EDT - Nasdaq Real Time Price
Company EventsGet Company Events for:
Upcoming Events 
DateEventReminder
5-Aug-14Earnings announcementSet a Reminder
Recent Events 
DateEvent
7-May-14AVANIR PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
7-May-14AVANIR PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report
6-May-14AVANIR PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
6-May-14Avanir Pharmaceuticals Earnings Call scheduled for 4:30 pm ET today
5-May-14AVANIR PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
2-May-14Avanir Pharmaceuticals upgraded by Mizuho
19-Mar-14AVANIR PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers
19-Feb-14AVANIR PHARMACEUTICALS, INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Sub
6-Feb-14AVANIR PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report
5-Feb-14AVANIR PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
17-Jan-14AVANIR PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
10-Jan-14AVANIR PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers
11-Dec-13AVANIR PHARMACEUTICALS, INC. Files SEC form 10-K, Annual Report
10-Dec-13AVANIR PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Financi
15-Nov-13AVANIR PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Materia
29-Oct-13AVANIR PHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
12-Aug-13AVANIR PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement
8-Aug-13AVANIR PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report
6-Aug-13AVANIR PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
5-Jul-13AVANIR PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events